FidoCure blog | Dr. Dorothy Jackson Girimonte

Posts by:

Dr. Dorothy Jackson Girimonte

Dr. Dorothy Jackson Girimonte DVM, Diplomate ACVIM (Oncology), CVA Board certified in Medical Oncology 2015

Splenic Hemangiosarcoma Case Study: Pita

With a combination approach that included FidoCure® therapy, Pita lived for a year following a hemoabdomen and diagnosis of splenic hemangiosarcoma.

Mesothelioma Case Study: Heidi

With combination therapy that included targeted therapy guided by FidoCure® genomic sequencing, Heidi has survived over a year following her initial diagnosis of mesothelioma and is still going strong.

Telangiectatic Osteosarcoma Case Study: Scout

With a combination approach that included FidoCure® therapy, Scout has lived for 1.5 years after his initial diagnosis of telangiectatic osteosarcoma.

Anal Sac Adenocarcinoma Case Study: Brady

Transitional Cell Carcinoma Case Study: Ruby

With the help of FidoCure® therapy, Ruby had a great quality of life for 2 years after her initial diagnosis of transitional cell carcinoma.

Amelanotic Melanoma Case Study: Phinn

With the help of FidoCure® therapy, Phinn has lived a great quality of life for over 18 months after his initial diagnosis of amelanotic melanoma and is still going strong!

Jejunal Adenocarcinoma Case Study: Callie

With surgery and FidoCure® therapy, Callie is alive and well almost 20 months after her initial diagnosis of jejunal adenocarcinoma.

Osteosarcoma Case Study: Jade

With a combination approach that included FidoCure® therapy, Jade is alive and well 2 years after her initial diagnosis of osteosarcoma.

Insulinoma Case Study: Winston

With a combination approach that included FidoCure®, Winston survived two years following his initial diagnosis of metastatic insulinoma.

FidoCure^® Veterinary Team Blog

Read the latest in veterinary oncology research and FidoCure^® scientific and clinical updates from our team of experts and advisors

Dr. Dorothy Jackson Girimonte

Splenic Hemangiosarcoma Case Study: Pita

With a combination approach that included FidoCure® therapy, Pita lived for a year following a hemoabdomen and diagnosis of splenic hemangiosarcoma.

Mesothelioma Case Study: Heidi

With combination therapy that included targeted therapy guided by FidoCure® genomic sequencing, Heidi has survived over a year following her initial diagnosis of mesothelioma and is still going strong.

Telangiectatic Osteosarcoma Case Study: Scout

With a combination approach that included FidoCure® therapy, Scout has lived for 1.5 years after his initial diagnosis of telangiectatic osteosarcoma.

Anal Sac Adenocarcinoma Case Study: Brady

Transitional Cell Carcinoma Case Study: Ruby

With the help of FidoCure® therapy, Ruby had a great quality of life for 2 years after her initial diagnosis of transitional cell carcinoma.

Amelanotic Melanoma Case Study: Phinn

With the help of FidoCure® therapy, Phinn has lived a great quality of life for over 18 months after his initial diagnosis of amelanotic melanoma and is still going strong!

Jejunal Adenocarcinoma Case Study: Callie

With surgery and FidoCure® therapy, Callie is alive and well almost 20 months after her initial diagnosis of jejunal adenocarcinoma.

Osteosarcoma Case Study: Jade

With a combination approach that included FidoCure® therapy, Jade is alive and well 2 years after her initial diagnosis of osteosarcoma.

Insulinoma Case Study: Winston

With a combination approach that included FidoCure®, Winston survived two years following his initial diagnosis of metastatic insulinoma.

FidoCure® Veterinary Team Blog

Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates from our team of experts and advisors

Dr. Dorothy Jackson Girimonte

With a combination approach that included FidoCure® therapy, Pita lived for a year following a hemoabdomen and diagnosis of splenic hemangiosarcoma.

With combination therapy that included targeted therapy guided by FidoCure® genomic sequencing, Heidi has survived over a year following her initial diagnosis of mesothelioma and is still going strong.

With a combination approach that included FidoCure® therapy, Scout has lived for 1.5 years after his initial diagnosis of telangiectatic osteosarcoma.

With the help of FidoCure® therapy, Ruby had a great quality of life for 2 years after her initial diagnosis of transitional cell carcinoma.

With the help of FidoCure® therapy, Phinn has lived a great quality of life for over 18 months after his initial diagnosis of amelanotic melanoma and is still going strong!

With surgery and FidoCure® therapy, Callie is alive and well almost 20 months after her initial diagnosis of jejunal adenocarcinoma.

With a combination approach that included FidoCure® therapy, Jade is alive and well 2 years after her initial diagnosis of osteosarcoma.

With a combination approach that included FidoCure®, Winston survived two years following his initial diagnosis of metastatic insulinoma.

FidoCure^® Veterinary Team Blog

Read the latest in veterinary oncology research and FidoCure^® scientific and clinical updates from our team of experts and advisors